AmerisourceBergen
ABC
Delayed Nyse - 09/24 10:00:49 pm
89.57USD
-0.62%
Prev.90.1300
Open89.6500
High90.1900
Low88.4400
Volume1 853 184
Financials
Sales 2018 168 B
EBIT 2018 2 005 M
R. net 2018 1 709 M
Debt 2018 1 068 M
Rend. 2018 1,69%
P/E ratio 2018 11,42
P/E ratio 2019 14,17
EV / Sales 2018 0,12x
EV / Sales 2019 0,11x
Capitalization 19 500 M
Company
AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care.It operates through the Pharmaceutical Distribution and Other segments.The Pharmaceutical Distribution segment distributes a comprehensive offering of brand-name, specialty...
Sector :
Drug Retailers - NEC
Calendar :
2018-11-01 Earnings Release
Trading Rating :
Investor Rating :
Latest news
09/22AMERISOURCEBERGEN : Sen. Hyde-Smith Calls for 'All-Hands-on-Deck Approach' to Fighting Mississippi's Opioid Problem
AQ
09/20AMERISOURCEBERGEN : Announces Financial Leadership Change
AQ
09/10AMERISOURCEBERGEN : Drug Distributor AmerisourceBergen Names New Finance Chief
DJ
09/10AMERISOURCEBERGEN : Announces Financial Leadership Change
BU
09/06AMERISOURCEBERGEN : Meetings, roundtables and tours
AQ
09/05AMERISOURCEBERGEN CORP : Regulation FD Disclosure (form 8-K)
AQ
08/27AMERISOURCEBERGEN : Florida Coalition Alliance and the AmerisourceBergen Foundation Team Up to Bring Digital Courses Aimed at Combating Opioid Misuse to Florida High Schools
AQ
08/27AMERISOURCEBERGEN : IntrinsiQ Specialty Solutions' New MarketTREND Tool Provides Unparalleled Market Analysis Reports to Manufacturers
AQ
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralNeutral
Resistance91,194,9105
Spread/Res.-1,6%-5,6%-15%
Spread/Supp.1,8%13%20%
Support88,079,074,8